World Cancer Day: trends in cancer therapeutics to look forward to in 2025

Original source here.

‍

Can artificial intelligence boost cancer drug discovery in 2025?

Additionally, it is no surprise that artificial intelligence (AI) is bound to play a role in diagnosing cancer and in drug discovery.

“In 2025, the adoption of AI across various sectors of healthcare and life sciences is expected to accelerate significantly,” said Ofer Sharon, CEO of OncoHost. “AI-powered diagnostic tools are anticipated to achieve broader adoption in clinical settings, enhancing diagnostic precision and enabling more personalized patient care.”

Combination therapies deemed a “financial strain”; need for cost-effective measures

However, this year, the growing approval of combination drug therapies is expected to place added financial strain on healthcare systems, Sharon pointed out.

“This trend will likely prompt the implementation of more restrictive reimbursement schemes as a countermeasure to rising costs. As a result, pricing pressures will intensify, driving the need for cost-effective solutions,” said Sharon.

This may lead to a stronger focus on the adoption of companion diagnostics to ensure that the right patients are enrolled in drug trials to best observe the efficacy of cancer medicines.

As more and more cancer therapies pave their way through the clinic and scientists seek to improve the safety and efficacy of existing medicines, it’s safe to say that oncology research and development (R&D) is busier than ever, and 2025 is hoped to beat that.

‍